S158: EFFICACY OF LOW-DOSE TYROSINE KINASE INHIBITOR THERAPY AFTER ACHIEVING MAJOR MOLECULAR RESPONSE IN PERSONS WITH CHRONIC MYELOID LEUKAEMIA

• Zongru LI,
• Yijing Zhao,
• Linping Lu,
• Yong Guo,
• Ya-Zhen Qin,
• Qian Jiang

Affiliations

Zongru LI

1 Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China

Yijing Zhao

1 Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China

Linping Lu

2 Tsinghua University, Department of Biomedical Engineering, Beijing, China

Yong Guo

2 Tsinghua University, Department of Biomedical Engineering, Beijing, China

Ya-Zhen Qin

1 Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China

Qian Jiang

1 Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China